Similar articles

• Statin-induced necrotizing autoimmune myopathy: importance of early recognition.

  Hussenbux A, Hofer M, Steuer A. Hussenbux A, et al. Br J Hosp Med (Lond). 2017 Jun 2;78(6):352-353. doi: 10.12968/hmed.2017.78.6.352. Br J Hosp Med (Lond). 2017. PMID: 28614015 No abstract available.
• Identifying statin-associated autoimmune necrotizing myopathy.

  Albayda J, Christopher-Stine L. Albayda J, et al. Cleve Clin J Med. 2014 Dec;81(12):736-41. doi: 10.3949/ccjm.81a.13158. Cleve Clin J Med. 2014. PMID: 25452351 Review.
• [Autoimmune myopathy associated with statin use].

  Ljøstad U, Mygland Å. Ljøstad U, et al. Tidsskr Nor Laegeforen. 2016 Sep 13;136(16):1360-2. doi: 10.4045/tidsskr.16.0340. eCollection 2016 Sep. Tidsskr Nor Laegeforen. 2016. PMID: 27637055 Review. Norwegian.
• [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].

  Hinschberger O, Lohmann C, Lannes B, Martzolff L, Vo BD, Jaeger-Bizet F, Ciobanu E, Kieffer P. Hinschberger O, et al. Rev Med Interne. 2014 Aug;35(8):546-9. doi: 10.1016/j.revmed.2013.06.009. Epub 2013 Jul 30. Rev Med Interne. 2014. PMID: 23910221 French.
• Immune-mediated necrotising myopathy linked to statin use.

  Kipfer S, Frigerio S, Hench J, Aussy A, Boyer O. Kipfer S, et al. Lancet. 2015 Oct 31;386(10005):e26. doi: 10.1016/S0140-6736(15)60068-X. Epub 2015 Jun 11. Lancet. 2015. PMID: 26074381 No abstract available.